India took a much-needed step in the fight against obesity and diabetes with the introduction of Mounjaro (tirzepatide), a ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

Eli Lilly's Mounjaro, a new diabetes and weight loss drug, is making waves in India. Approved by the drug regulator, this ...

A patient in India may have to spend approximately $200 per month for ... Following marketing authorization from the CDSCO, ...

Also in this newsletter, the weight-loss drug Mounjaro makes its India debut and stock markets on ‘liberation day’ ...

According to the journal Second Nature, Mounjaro supports weight loss of around four per cent of body weight after one month, ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

In a nation where the battle against the stomach bulge is as intense as the love for butter parathas, a new player has ...

The new weight loss drug entering the Indian market, Mounjaro, Trinamool Congress' MP Abhishek Banerjee's Diamond Harbour Model and his political ascent in West Bengal and the Waqf Amendment Bill, ...

It is being billed by doctors as the best drug in weight management, compared to similar drugs available in the market ...